Item: Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl
Rating: Unrated
Author: Morningstar

Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl

32.694 (1.853%)

NAV on July 26, 2024

Category Equity:
Sector - Healthcare

Investment StyleBox

Large Growth

Total Assets 949 cr

Turnover Ratio 23.30%

Expense Ratio 0.79%

Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days

Returns

1M: 7.34%
1Y: 48.00%
3M: 12.19%
3Y: 18.00%
6M: 19.88%
5Y: 27.73%

Min Investment 5,000

Buy Now Start SIP

SECTOR WEIGHTINGS (%)

Financial 0.0%

Industrial 0.0%

Technology 0.0%

Basic Materials 2.26%

Consumer Cyclical 0.0%

Utilities Services 0.0%

Healthcare Services 97.74%

Energy Services 0.00%

Communication Services 0.00%

Consumer Defensive 0.00%

Real Estate 0.00%

INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Dividends that would otherwise be paid out to investors are instead used to purchase more units in the fund. Not as tax efficient as Growth.

View Factsheet

Top Rated
Top Performing

-

Best Sector Healthcare Funds

NAME	LATEST NAV	RETURNS 1y	FUND ASSETS	Expense RATIO	RISK
Quant Healthcare Fund Direct Growth	16.368	62.21%	302 cr	0.68%	-
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth	37.660	53.21%	4,125 cr	1.07%	-
UTI Healthcare Fund-Growth Option- Direct	287.671	48.34%	986 cr	1.3%	-
Tata India Pharma & Healthcare Fund Direct Growth	32.694	48.00%	949 cr	0.79%	-
SBI Healthcare Opportunities Fund Direct Growth	422.123	38.62%	2,760 cr	0.94%	-